These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 34522589)

  • 21. PLGA nanoparticles modified with a BBB-penetrating peptide co-delivering Aβ generation inhibitor and curcumin attenuate memory deficits and neuropathology in Alzheimer's disease mice.
    Huang N; Lu S; Liu XG; Zhu J; Wang YJ; Liu RT
    Oncotarget; 2017 Oct; 8(46):81001-81013. PubMed ID: 29113362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
    Solé M; Esteban-Lopez M; Taltavull B; Fábregas C; Fadó R; Casals N; Rodríguez-Álvarez J; Miñano-Molina AJ; Unzeta M
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2189-2202. PubMed ID: 31047972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of β-amyloid on blood-brain barrier properties and function.
    Petrushanko IY; Mitkevich VA; Makarov AA
    Biophys Rev; 2023 Apr; 15(2):183-197. PubMed ID: 37124923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer's disease model mouse.
    Shang J; Yamashita T; Tian F; Li X; Liu X; Shi X; Nakano Y; Tsunoda K; Nomura E; Sasaki R; Tadokoro K; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
    Brain Res; 2019 Nov; 1723():146379. PubMed ID: 31415766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1,25-Dihydroxyvitamin D3 regulates expression of LRP1 and RAGE in vitro and in vivo, enhancing Aβ1-40 brain-to-blood efflux and peripheral uptake transport.
    Guo YX; He LY; Zhang M; Wang F; Liu F; Peng WX
    Neuroscience; 2016 May; 322():28-38. PubMed ID: 26820600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of Matrix Metallopeptidase 9 on Beta-Amyloid Elimination Across the Blood-Brain Barrier.
    Shackleton B; Ringland C; Abdullah L; Mullan M; Crawford F; Bachmeier C
    Mol Neurobiol; 2019 Dec; 56(12):8296-8305. PubMed ID: 31209784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A hybrid siRNA delivery complex for enhanced brain penetration and precise amyloid plaque targeting in Alzheimer's disease mice.
    Zheng X; Pang X; Yang P; Wan X; Wei Y; Guo Q; Zhang Q; Jiang X
    Acta Biomater; 2017 Feb; 49():388-401. PubMed ID: 27845275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders.
    Sim TM; Tarini D; Dheen ST; Bay BH; Srinivasan DK
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
    van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies for Targeted Delivery of Exosomes to the Brain: Advantages and Challenges.
    Choi H; Choi K; Kim DH; Oh BK; Yim H; Jo S; Choi C
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes of blood-brain-barrier function and transfer of amyloid beta in rats with collagen-induced arthritis.
    Lai PH; Wang TH; Zhang NY; Wu KC; Yao CJ; Lin CJ
    J Neuroinflammation; 2021 Jan; 18(1):35. PubMed ID: 33516259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic delivery to central nervous system by engineered PLGA nanoparticles.
    Cai Q; Wang L; Deng G; Liu J; Chen Q; Chen Z
    Am J Transl Res; 2016; 8(2):749-64. PubMed ID: 27158367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential mechanisms of Aβ-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease.
    Wan W; Chen H; Li Y
    Int J Neurosci; 2014 Feb; 124(2):75-81. PubMed ID: 23855502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatment.
    Loureiro JA; Gomes B; Fricker G; Coelho MAN; Rocha S; Pereira MC
    Colloids Surf B Biointerfaces; 2016 Sep; 145():8-13. PubMed ID: 27131092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crossing the blood-brain barrier with nanoparticles.
    Zhou Y; Peng Z; Seven ES; Leblanc RM
    J Control Release; 2018 Jan; 270():290-303. PubMed ID: 29269142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier.
    Storck SE; Meister S; Nahrath J; Meißner JN; Schubert N; Di Spiezio A; Baches S; Vandenbroucke RE; Bouter Y; Prikulis I; Korth C; Weggen S; Heimann A; Schwaninger M; Bayer TA; Pietrzik CU
    J Clin Invest; 2016 Jan; 126(1):123-36. PubMed ID: 26619118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
    Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
    Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbon nanotubes for delivery of small molecule drugs.
    Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G
    Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.